Page 312 - Syndipharma
P. 312

Modava Pharmaceutical






         No  Type             Brand Name   Product          Dosage    Strength  Indication        Status
                                                            Form
         16  Oncology         EXJADE TAB   DEFERASIROX TAB-   FOR SUS-   500 mg   Iron chelating agents   In the
                              500MG        LET, FOR SUSPEN-  PENSION           (Thalacemia)       Market
                                           SION ORAL 500 mg   ORAL
         17  Oncology         JADENU 180   DEFERASIROX TAB-  TABLET   180 mg   Iron chelating agents   In the
                              MG           LET ORAL 180 mg   ORAL              (Thalacemia)       Market       IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
         18  Oncology         JADENU 360   DEFERASIROX TAB-  TABLET   360 mg   Iron chelating agents   In the
                              MG           LET ORAL 360 mg   ORAL              (Thalacemia)       Market
         19  Oncology         JADENU 90    DEFERASIROX TAB-  TABLET    90 mg   Iron chelating agents   In the
                              MG           LET ORAL 90 mg   ORAL               (Thalacemia)       Market
         20  CNS              LEPONEX TAB   CLOZAPINE TABLET   TABLET   100 mg   ANTIPSYCHOTICS   In the
                              100MG        ORAL 100 mg      ORAL                                  Market
         21  MS               Marela HGC   FINGOLIMOD CAP-  CAPSULE    0.5 mg   IMMUNOSUPPRES-    In the
                              0.5MG        SULE ORAL 0.5 mg   ORAL             SANTS              Market
         22  Organ transplanta-  MYFORTIC   MYCOPHENOLIC     TABLET,    10 mg  IMMUNOSUPPRES-     In the
             tion             FCT360MG     ACID TABLET, DE-  DELAYED           SANTS              Market
                                           LAYED RELEASE ORAL  RELEASE
                                           360 mg           ORAL
         23  CNS              RITALIN TAB   METHYLPHENIDATE   TABLET    10 mg   PSYCHOSTIMULANTS,   In the
                              10MG         HYDROCHLORIDE    ORAL               AGENTS USED FOR    Market
                                           TABLET ORAL 10 mg                   ADHD AND NOOT-
                                                                               ROPICS
         24  Organ transplanta-  NEORAL SGC   CICLOSPORIN CAP-  CAPSULE   100 mg   IMMUNOSUPPRES-  In the
             tion             100MG        SULE ORAL 100 mg   ORAL             SANTS              Market
         25  Organ transplanta-  NEORAL SGC   CICLOSPORIN CAP-  CAPSULE   25 mg   IMMUNOSUPPRES-  In the
             tion             25MG         SULE ORAL 25 mg   ORAL              SANTS              Market
         26  Organ transplanta-  NEORAL SGC   CICLOSPORIN CAP-  CAPSULE   50 mg   IMMUNOSUPPRES-  In the
             tion             50MG         SULE ORAL 50 mg   ORAL              SANTS              Market
         27  CNS              SIRDALUD TAB  TIZANIDINE TABLET   TABLET    4 mg   MUSCLE RELAXANTS,   In the
                              4MG          ORAL 4 mg        ORAL               CENTRALLY ACTING   Market
                                                                               AGENTS
         28  CNS              TEGRETOL CR   CARBAMAZEPINE    TABLET,   200 mg   ANTIEPILEPTICS    In the
                              FCT 200MG    TABLET, EXTENDED   EXTENDED                            Market
                                           RELEASE ORAL 200   RELEASE
                                           mg               ORAL
         29  CNS              TEGRETOL CR   CARBAMAZEPINE    TABLET,    400 mg   ANTIEPILEPTICS   In the
                              FCT 400MG    TABLET, EXTENDED   EXTENDED                            Market
                                           RELEASE ORAL 400   RELEASE
                                           mg               ORAL
         30  NSAID            VOLTAREN FCT  DICLOFENAC SODI-   TABLET,    50 mg   ANTIINFLAMMATORY   In the
                              50MG         UM TABLET, DELAYED  EXTENDED        AND ANTIRHEUMATIC   Market
                                           RELEASE ORAL 50 mg  RELEASE         PRODUCTS
                                                            ORAL
         31  NSAID            VOLTAREN SR   DICLOFENAC       TABLET,    100 mg   ANTIINFLAMMATORY   In the
                              75MG         SODIUM TABLET,   EXTENDED           AND ANTIRHEUMATIC   Market
                                           EXTENDED RELEASE   RELEASE          PRODUCTS
                                           ORAL 100 mg      ORAL
         32  NSAID            VOLTAREN R   DICLOFENAC        TABLET,    75 mg   ANTIINFLAMMATORY   In the
                              FCT100MG     SODIUM TABLET,   EXTENDED           AND ANTIRHEUMATIC   Market
                                           EXTENDED RELEASE   RELEASE          PRODUCTS
                                           ORAL 75 mg       ORAL
         33  ANTIHISTAMINE    ZADITEN TAB   KETOTIFEN TABLET   TABLET   1 mg   ANTIHISTAMINES FOR   In the
                              1MG          ORAL 1 mg        ORAL               SYSTEMIC USE       Market
                                                                                                             311
   307   308   309   310   311   312   313   314   315   316   317